Medical Professionals

BONESUPPORT™ develops and markets CERAMENT®, an innovative range of radiopaque injectable osteoconductive and drug-eluting bioceramic products that have a proven ability to heal defects by remodelling to host bone in six to twelve months.

The addition of antibiotics (gentamicin) CERAMENT G and vancomycin CERAMENT V to the CERAMENT platform technology, protects the bone healing by preventing colonization of antimicrobial sensitive microorganisms. The product characteristic enables a single-stage procedure strategy for the management of deep bone infection, which is patient-friendly and may result in improved outcomes by fewer surgical procedures, shorter hospitalization, fewer reinfections, and lower costs.

CERAMENT is effective in treating patients with fractures and bone voids caused by trauma, infection, disease or related surgery.